Elsevier to publish Phytochemistry Letters

April 03, 2007

Amsterdam, 3 April 2007 - Elsevier announced today the launch of a new scientific journal, Phytochemistry Letters, in collaboration with the Phytochemical Society of Europe (PSE) (http://www.phytochemicalsociety.org). Phytochemistry Letters will focus on the rapid publication of high-impact preliminary research covering all areas of natural product science, and will be published quarterly, starting in 2008.

Articles, of 3-4 pages in length, will be reviewed within two weeks of submission, with accepted papers published online within one week. Dr Simon Gibbons from the School of Pharmacy, University of London, who is the Editor-in-Chief, will be supported by a panel of Subject Editors and an extensive Editorial Board of internationally renowned experts in natural product science. Dr. Gibbons said "There was a clear need for a quality journal for short communications in this field, which will be satisfied through the launch of this exciting new publication." Both he and the PSE are happy to have Elsevier as their publishing partner for this endeavor, and are looking forward to a successful publishing relationship.

Dr. James Milne, Publisher for organic and inorganic chemistry at Elsevier, added "I was delighted to extend the collaboration between the PSE and Elsevier. The society's 50th Anniversary Symposium (http://www.pse50.com) is being organized by Elsevier, in Cambridge, UK this April, and Elsevier also publishes the leading international journal Phytochemistry, an official journal of both the PSE and the PSNA (Phytochemical Society of North America). The working relationship between the PSE and Elsevier is both established and highly effective, providing a mutually beneficial platform on which to develop this important new publication for the natural product scientific community."
-end-
About the Phytochemical Society of Europe

The Phytochemical Society of Europe (http://www.phytochemicalsociety.org) exists to serve all those with an interest in natural product chemistry and biochemistry and in the applications of such knowledge in academia, industry and agriculture. The Society organizes at least three conferences a year in Europe and specializes in organizing young scientists symposia.

About Elsevier Society Publishing

Elsevier is committed to building unique, long-lasting relationships to help societies to achieve their publishing goals and provide value-added member services. Elsevier partners with more than 500 international learned societies, professional associations and research institutes. To learn more, please visit the Society homepage (http://www.elsevier.com/wps/find/societyhome.societies) on Elsevier.com.

About Elsevier

Elsevier is a world-leading publisher of scientific, technical and medical information products and services. Working in partnership with the global science and health communities, Elsevier's 7,000 employees in over 70 offices worldwide publish more than 2,000 journals and 1,900 new books per year, in addition to offering a suite of innovative electronic products, such as ScienceDirect (http://www.sciencedirect.com), MD Consult (http://www.mdconsult.com), Scopus (http://www.info.scopus.com), bibliographic databases, and online reference works.

Elsevier (http://www.elsevier.com) is a global business headquartered in Amsterdam, The Netherlands and has offices worldwide. Elsevier is part of Reed Elsevier Group plc (http://www.reedelsevier.com), a world-leading publisher and information provider. Operating in the science and medical, legal, education and business-to-business sectors, Reed Elsevier provides high-quality and flexible information solutions to users, with increasing emphasis on the Internet as a means of delivery. Reed Elsevier's ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

Elsevier

Related Gibbons Articles from Brightsurf:

New fossil ape is discovered in India
A 13-million-year-old fossil unearthed in northern India comes from a newly discovered ape, the earliest known ancestor of the modern-day gibbon.

Babies born prematurely can catch up their immune systems, study finds
Researchers from King's College London & Homerton University Hospital have found babies born before 32 weeks' gestation can rapidly acquire some adult immune functions after birth, equivalent to that achieved by infants born at term.

Study calculates links between prescription medications and risk for suicide
A review of 922 prescription medications taken by almost 150 million people over an 11-year period shows that just 10 of these drugs were associated with an increased rate of suicide attempts.

Gibbons' large, long-term territories put them under threat from habitat loss
Wild gibbons living in the peat swamps of southern Borneo require between 20 and 50 hectares of forest territory for each group, making their populations particularly vulnerable to habitat loss, according to a study publishing July 31 in the open-access journal PLOS ONE by Dr.

Study reveals new genomic roots of ecological adaptation in polar bear evolution
Scientists from the University of Massachusetts Amherst, Vanderbilt University and Clark University have shed new light on the genomic foundation of the polar bear's ecological adaption by pinpointing rapid changes in the bear's gene copy numbers in response to a diet shifting from vegetation to meat.

2017 North Korean nuclear test 10 times larger than previous tests, new study finds
North Korea detonated a nuclear device in 2017 equivalent to about 250 kilotons of TNT, a new study in AGU's Journal of Geophysical Research: Solid Earth estimates.

Risk of suicide attempt by children doubles if parent uses opioids
In a tale of two epidemics, researchers from the University of Chicago and the University of Pittsburgh found that children of parents who use opioids have an increased risk of attempting suicide.

Parental use of prescription opioids associated with risk of suicide attempt by children
Opioid use by parents was associated with increased risk of suicide attempt by their children in a study that linked medical claims for opioid prescriptions for parents with medical claims for suicide attempts by their children.

For-profit dialysis provider charges private insurers 4 times more than government payers
Private insurers covering people receiving treatment for dialysis paid four times more than government insurance programs such as Medicare paid for the same service.

ZEB1 throttles therapeutic target, protecting KRAS-mutant lung cancer
A cellular identity switch protects a cancer-promoting genetic pathway from targeted therapy, researchers at The University of Texas MD Anderson Cancer Center today reported in Science Translational Medicine.

Read More: Gibbons News and Gibbons Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.